MedTrace Logo

Bioequivalence Study of Pravastatin Sodium Tablets 80 mg Under Fasting Conditions

NCT01146106 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2010-06-17

No results posted yet for this study

Summary

This is a single Dose Two-Way Crossover Fasting Bioequivalence Study of Pravastatin 80 mg Tablets of Dr.Reddy's Laboratories Limited with Pravachol 80 mg, Bristol Myers Squibb in Healthy Volunteers.

Conditions

  • Healthy

Interventions

DRUG

Pravastatin Sodium

Pravastatin Sodium Tablets 80 mg

Sponsors & Collaborators

  • Dr. Reddy's Laboratories Limited

    lead INDUSTRY

Principal Investigators

  • Ralph Scallion EE, MD · AAI, 6101 Quadrangle Drive, Chapel Hill, NC 27514

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-12-31
Primary Completion
2002-12-31
Completion
2002-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01146106 on ClinicalTrials.gov